查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827009

2025年全球腹疝氣治療市場報告

Ventral Hernia Treatment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，腹疝氣治療市場規模強勁成長，從2024年的48.7億美元增加至2025年的52.2億美元，複合年成長率為7.2%。預測期內的成長可歸因於肥胖盛行率的上升、人們對腹疝氣的認知不斷提高、人口老化、可支配收入的增加以及對微創外科手術的需求不斷成長。

預計未來幾年腹疝氣治療市場規模將強勁成長，到2029年將達到68.4億美元，複合年成長率為7.0%。預測期內的成長可歸因於門診手術需求的增加、醫療保健支出的增加、政府措施的增加、疝氣修補手術需求的增加以及研發投入的增加。預測期內的主要趨勢包括先進的疝氣修補設備、生物可吸收材料、策略合作、機器人輔助手術設備和遠端監控。

腹疝氣治療涉及透過醫療程序和干涉措施來修復腹壁疝氣。常用方法包括機器人輔助手術、無張力網片修補和腹腔鏡腹腔內手術。治療目標是復位組織、加強腹壁並防止復發，最終緩解疼痛、恢復正常功能並減少腸阻塞和絞窄等併發症。

腹疝氣的主要治療方法包括上腹疝氣、臍疝氣和切口疝氣。上腹疝氣是指脂肪組織從胸骨和肚臍之間上腹壁的薄弱區域擠壓而發生。診斷可透過超音波、電腦斷層掃描 (CT) 或磁振造影(MRI) 進行。治療方案包括各種外科手術，例如開放式疝氣修補術、腹腔鏡手術和機器人疝氣修補術。這些手術可在醫院、門診手術中心和診所進行。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，其中許多產品的國內替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供腹部疝氣治療市場統計數據，包括全球市場規模、各地區市場佔有率、腹疝氣治療市場佔有率的競爭對手、詳細的腹疝治療細分市場、市場趨勢和機遇，以及您在腹疝氣治療行業取得成功所需的數據。本腹疝氣治療市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年7.0%的成長率預測較先前的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致法國和韓國開發的合成網狀植入和機器人疝氣修補系統價格上漲，進而影響美國的外科手術效果，導致手術延誤和一般外科手術費用增加。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響可能會產生更廣泛的影響。

肥胖盛行率的上升是腹疝氣治療市場成長的主要原因。肥胖是一種以體內脂肪過多為特徵的疾病，它會對腹壁造成壓力，增加腹疝氣的風險。不良飲食、久坐不動的生活方式、遺傳易感性和缺乏運動等因素導致全球肥胖率上升。腹疝氣治療在控制肥胖相關併發症發揮重要作用，可以減輕腹部壓力、降低疝氣復發風險並增強整體腹部肌肉力量。根據世界衛生組織 (WHO) 的數據，截至 2024 年 3 月，全球八分之一的人將與肥胖作鬥爭，其中包括 25 億超重成年人和 8.9 億肥胖者。此外，據報導有 3,700 萬名五歲以下兒童肥胖。預計這種肥胖流行病將推動對腹疝氣治療的需求。

疝氣治療的技術進步進一步推動了市場成長。各公司正在開發創新解決方案，例如腹腔鏡和開放式疝氣網片固定裝置，以改善手術效果和患者復原。腹腔鏡和開放式疝氣網片固定裝置可在使用微創（腹腔鏡）或傳統開放式方法的疝氣修補手術中固定網片。 LIQUIFIX FIX8 專為微創疝氣修補手術而設計，而 LIQUIFIX Precision 則針對開放式股疝氣和腹股溝疝氣開放性手術進行了最佳化。這些經核准的設備使用液體錨來固定網片而不會穿透組織，從而減少創傷並最大限度地減少併發症。美國每年進行超過 120 萬例疝氣修補手術，這些進步提供了更安全、更精確的治療選擇。

2023年8月，Steris plc收購了Becton, Dickinson & Company的手術器械資產，以增強其醫療保健產品組合。此次收購使Steris plc能夠擴大其在手術器械市場的產品供應，為醫院和手術中心提供先進的工具和技術。透過整合這些資產，Steris plc將增強其在醫療設備產業提供全面解決方案的能力，同時支持腹疝氣治療市場的成長。

腹疝氣治療市場由提供外科諮詢、疝氣修補手術、術後護理和診斷影像等服務的營業單位所獲得的收益所構成。市場規模包括服務提供者銷售的或包含在其服務產品中的任何相關商品的價值。腹疝氣治療市場還包括固定裝置、手術器械、創傷護理產品、手術縫合線和縫合器的銷售。該市場中的商品價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腹疝氣治療：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球腹疝氣治療市場：成長率分析
  • 全球腹疝氣治療市場表現：規模與成長，2019-2024
  • 全球腹疝氣治療市場預測：規模與成長，2024-2029，2034
  • 全球腹疝氣治療：總目標市場（TAM）

第6章 市場細分

  • 全球腹疝氣治療市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 上腹疝氣（胃疝氣）
  • 臍疝氣
  • 切口疝
  • 全球腹疝氣治療市場（依診斷、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 超音波
  • 電腦斷層掃描（CT）
  • 磁振造影（MRI）
  • 全球腹疝氣治療市場（依手術、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 開放性疝氣手術
  • 腹腔鏡手術
  • 機器人疝氣手術
  • 全球腹疝氣治療市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 診所
  • 全球腹疝氣治療市場：上腹部（胃腸）疝氣細分，按類型、業績和預測，2019-2024 年、2024-2029 年、2034 年
  • 小上腹疝
  • 大型上腹疝
  • 全球腹疝氣治療市場：臍疝氣氣細分、類型、績效及預測（2019-2024、2024-2029、2034）
  • 先天性臍疝氣
  • 後臍疝氣
  • 全球腹疝氣治療市場：切口疝氣細分、類型、績效及預測（2019-2024、2024-2029、2034）
  • 原發性切口疝氣
  • 復發性切口疝氣

第7章 區域和國家分析

  • 全球腹疝氣治療市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球腹疝氣治療市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 腹疝氣治療市場：競爭格局
  • 腹疝氣治療市場：公司簡介
    • Johnson And Johnson Services Inc.
    • AbbVie
    • Abbott Laboratories
    • Medtronic Plc
    • Becton, Dickinson and Company（BD）

第31章：其他領先和創新企業

  • Baxter International Inc.
  • Braun Melsungen AG
  • Zimmer Biomet
  • Olympus Corporation
  • WL Gore and Associates Inc
  • STERIS Plc
  • Cook Medical Inc.
  • KARL STORZ
  • Cooper University Health Care
  • Molnlycke Health Care
  • Integra LifeSciences Holdings
  • ConMed Corporation
  • Aesculap Inc
  • Richard Wolf GmbH
  • Ethicon Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年腹疝氣治療市場：提供新機會的國家
  • 2029 年腹疝氣治療市場：細分市場帶來新機會
  • 2029年腹疝氣治療市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r34181u

Ventral hernia treatment involves medical procedures and interventions to repair hernias occurring in the abdominal wall. Common approaches include robotic-assisted surgery, tension-free mesh repair, and laparoscopic intraperitoneal techniques. The goal of treatment is to reposition displaced tissues, reinforce the abdominal wall, and prevent recurrence, ultimately relieving pain, restoring normal function, and reducing complications such as bowel obstruction or strangulation.

The primary types of ventral hernia treatment include epigastric (stomach area) hernia, umbilical (belly button) hernia, and incisional hernia. An epigastric hernia occurs when fatty tissue pushes through a weakened area in the upper abdominal wall between the sternum and the belly button. Diagnosis is performed using ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI). Treatment options include various surgical procedures such as open hernia surgery, laparoscopic surgery, and robotic hernia surgery. These treatments are utilized in hospitals, ambulatory surgical centers, and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The ventral hernia treatment market research report is one of a series of new reports from The Business Research Company that provides ventral hernia treatment market statistics, including ventral hernia treatment industry global market size, regional shares, competitors with a ventral hernia treatment market share, detailed ventral hernia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the ventral hernia treatment industry. This ventral hernia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ventral hernia treatment market size has grown strongly in recent years. It will grow from $4.87 billion in 2024 to $5.22 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increasing prevalence of obesity, increasing awareness about ventral hernias, growing aging population, rising disposable income, increasing demand for minimally invasive surgical procedures.

The ventral hernia treatment market size is expected to see strong growth in the next few years. It will grow to $6.84 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rising demand for outpatient procedures, rising spend on healthcare, increasing government initiatives, rising demand for hernia repair surgeries, increasing investment in research and development. Major trends in the forecast period include advanced hernia repair devices, bioabsorbable materials, strategic collaboration, robotic-assisted surgery devices, remote monitoring.

The forecast of 7.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. surgical outcomes by inflating prices of synthetic mesh implants and robotic hernia repair systems developed in France and South Korea, resulting in delayed procedures and higher general surgery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of obesity is significantly contributing to the growth of the ventral hernia treatment market. Obesity, a condition characterized by excessive body fat, increases the risk of ventral hernias due to the added strain on the abdominal wall. Factors such as poor diet, sedentary lifestyle, genetic predisposition, and lack of physical activity have led to an increase in obesity rates worldwide. Ventral hernia treatment plays a crucial role in managing complications associated with obesity by alleviating abdominal strain, reducing hernia recurrence risk, and improving overall abdominal strength. According to the World Health Organization (WHO), as of March 2024, one in eight people globally were struggling with obesity, including 2.5 billion overweight adults, with 890 million classified as obese. Additionally, 37 million children under the age of five were reported to be overweight. This growing obesity epidemic is expected to drive demand for ventral hernia treatments.

Technological advancements in hernia treatment are further propelling market growth. Companies are developing innovative solutions, such as laparoscopic and open hernia mesh fixation devices, to improve surgical outcomes and patient recovery. Laparoscopic and open hernia mesh fixation devices secure mesh during hernia repair surgeries, either through minimally invasive (laparoscopic) or traditional open approaches. In March 2024, TELA Bio Inc. introduced LIQUIFIX FIX8 and LIQUIFIX Precision in the U.S. The LIQUIFIX FIX8 device is designed for minimally invasive hernia repairs, while LIQUIFIX Precision is optimized for open femoral and inguinal hernia procedures. These FDA-approved devices utilize liquid anchors to secure mesh without penetrating tissue, thereby reducing trauma and minimizing complications. Given that over 1.2 million hernia procedures are performed annually in the U.S., such advancements offer safer and more precise treatment options.

In August 2023, Steris plc acquired the surgical instrumentation assets of Becton, Dickinson, and Company to strengthen its healthcare portfolio. This acquisition expands Steris plc's offerings in the surgical instrumentation market, allowing it to provide advanced tools and technologies to hospitals and surgical centers. By integrating these assets, Steris enhances its ability to deliver comprehensive solutions in the medical device industry while supporting growth in the ventral hernia treatment market.

Major players in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Molnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.

North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in ventral hernia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ventral hernia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ventral hernia treatment market consists of revenues earned by entities by providing services such as surgical consultations, hernia repair surgeries, post-operative care, diagnostic imaging and others. The market value includes the value of related goods sold by the service provider or included within the service offering. The ventral hernia treatment market also includes sales of fixation devices, surgical instruments, wound care products, surgical sutures and staplers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ventral Hernia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ventral hernia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ventral hernia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ventral hernia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Epigastric (Stomach Area) Hernia; Umbilical (Belly Button) Hernia; Incisional Hernia
  • 2) By Diagnosis: Ultrasound; Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI)
  • 3) By Surgery: Open Hernia Surgery; Laparoscopic Surgery; Robotic Hernia Surgery
  • 4) By End Users: Hospitals; Ambulatory Surgical Centres; Clinics
  • Subsegments:
  • 1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia; Large Epigastric Hernia
  • 2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia; Acquired Umbilical Hernia
  • 3) By Incisional Hernia: Primary Incisional Hernia; Recurrent Incisional Hernia
  • Companies Mentioned: Johnson And Johnson Services Inc.; AbbVie; Abbott Laboratories; Medtronic Plc; Becton, Dickinson and Company (BD); Baxter International Inc.; Braun Melsungen AG; Zimmer Biomet; Olympus Corporation; W.L. Gore and Associates Inc; STERIS Plc; Cook Medical Inc.; KARL STORZ; Cooper University Health Care; Molnlycke Health Care; Integra LifeSciences Holdings; ConMed Corporation; Aesculap Inc; Richard Wolf GmbH; Ethicon Inc; Tela Bio; Microline Surgical; Hernia Mesh S.R.L.; Insightra Medical Inc; Advanced MedTech Solutions Pvt Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ventral Hernia Treatment Market Characteristics

3. Ventral Hernia Treatment Market Trends And Strategies

4. Ventral Hernia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ventral Hernia Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Ventral Hernia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Ventral Hernia Treatment Market Growth Rate Analysis
  • 5.4. Global Ventral Hernia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Ventral Hernia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Ventral Hernia Treatment Total Addressable Market (TAM)

6. Ventral Hernia Treatment Market Segmentation

  • 6.1. Global Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Epigastric (Stomach Area) Hernia
  • Umbilical (Belly Button) Hernia
  • Incisional Hernia
  • 6.2. Global Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound
  • Computed Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • 6.3. Global Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Hernia Surgery
  • Laparoscopic Surgery
  • Robotic Hernia Surgery
  • 6.4. Global Ventral Hernia Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics
  • 6.5. Global Ventral Hernia Treatment Market, Sub-Segmentation Of Epigastric (Stomach Area) Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Epigastric Hernia
  • Large Epigastric Hernia
  • 6.6. Global Ventral Hernia Treatment Market, Sub-Segmentation Of Umbilical (Belly Button) Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Congenital Umbilical Hernia
  • Acquired Umbilical Hernia
  • 6.7. Global Ventral Hernia Treatment Market, Sub-Segmentation Of Incisional Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Incisional Hernia
  • Recurrent Incisional Hernia

7. Ventral Hernia Treatment Market Regional And Country Analysis

  • 7.1. Global Ventral Hernia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Ventral Hernia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ventral Hernia Treatment Market

  • 8.1. Asia-Pacific Ventral Hernia Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ventral Hernia Treatment Market

  • 9.1. China Ventral Hernia Treatment Market Overview
  • 9.2. China Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ventral Hernia Treatment Market

  • 10.1. India Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ventral Hernia Treatment Market

  • 11.1. Japan Ventral Hernia Treatment Market Overview
  • 11.2. Japan Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ventral Hernia Treatment Market

  • 12.1. Australia Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ventral Hernia Treatment Market

  • 13.1. Indonesia Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ventral Hernia Treatment Market

  • 14.1. South Korea Ventral Hernia Treatment Market Overview
  • 14.2. South Korea Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ventral Hernia Treatment Market

  • 15.1. Western Europe Ventral Hernia Treatment Market Overview
  • 15.2. Western Europe Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ventral Hernia Treatment Market

  • 16.1. UK Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ventral Hernia Treatment Market

  • 17.1. Germany Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ventral Hernia Treatment Market

  • 18.1. France Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ventral Hernia Treatment Market

  • 19.1. Italy Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ventral Hernia Treatment Market

  • 20.1. Spain Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ventral Hernia Treatment Market

  • 21.1. Eastern Europe Ventral Hernia Treatment Market Overview
  • 21.2. Eastern Europe Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ventral Hernia Treatment Market

  • 22.1. Russia Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ventral Hernia Treatment Market

  • 23.1. North America Ventral Hernia Treatment Market Overview
  • 23.2. North America Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ventral Hernia Treatment Market

  • 24.1. USA Ventral Hernia Treatment Market Overview
  • 24.2. USA Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ventral Hernia Treatment Market

  • 25.1. Canada Ventral Hernia Treatment Market Overview
  • 25.2. Canada Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ventral Hernia Treatment Market

  • 26.1. South America Ventral Hernia Treatment Market Overview
  • 26.2. South America Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ventral Hernia Treatment Market

  • 27.1. Brazil Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ventral Hernia Treatment Market

  • 28.1. Middle East Ventral Hernia Treatment Market Overview
  • 28.2. Middle East Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ventral Hernia Treatment Market

  • 29.1. Africa Ventral Hernia Treatment Market Overview
  • 29.2. Africa Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ventral Hernia Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Ventral Hernia Treatment Market Competitive Landscape
  • 30.2. Ventral Hernia Treatment Market Company Profiles
    • 30.2.1. Johnson And Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Ventral Hernia Treatment Market Other Major And Innovative Companies

  • 31.1. Baxter International Inc.
  • 31.2. Braun Melsungen AG
  • 31.3. Zimmer Biomet
  • 31.4. Olympus Corporation
  • 31.5. W.L. Gore and Associates Inc
  • 31.6. STERIS Plc
  • 31.7. Cook Medical Inc.
  • 31.8. KARL STORZ
  • 31.9. Cooper University Health Care
  • 31.10. Molnlycke Health Care
  • 31.11. Integra LifeSciences Holdings
  • 31.12. ConMed Corporation
  • 31.13. Aesculap Inc
  • 31.14. Richard Wolf GmbH
  • 31.15. Ethicon Inc

32. Global Ventral Hernia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ventral Hernia Treatment Market

34. Recent Developments In The Ventral Hernia Treatment Market

35. Ventral Hernia Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Ventral Hernia Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Ventral Hernia Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Ventral Hernia Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer